Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 2008 Mar 15; 68(6):1970-8.
View in:
PubMed
subject areas
Adenocarcinoma
Adenocarcinoma
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antimetabolites, Antineoplastic
Antimetabolites, Antineoplastic
Cell Line, Tumor
Cell Line, Tumor
Cetuximab
Cetuximab
Deoxycytidine
Deoxycytidine
Drug Delivery Systems
Drug Delivery Systems
ErbB Receptors
ErbB Receptors
Gold
Gold
Humans
Humans
Immunoconjugates
Immunoconjugates
Metal Nanoparticles
Metal Nanoparticles
Pancreatic Neoplasms
Pancreatic Neoplasms
authors with profiles
Priyabrata Mukherjee
Resham Bhattacharya